吸入胰岛素治疗糖尿病的研究进展

被引：2

作者：

王巍

机构：

[1] 天津市环湖医院内科

来源：

医学综述 | 2009年 / 15卷 / 03期

关键词：

吸入胰岛素; 糖尿病; 糖化血红蛋白;

D O I：

暂无

中图分类号：

R587.1 [糖尿病];

学科分类号：

1002 ; 100201 ;

摘要：

糖尿病严重危害人类的身体健康。许多糖尿病患者的降糖治疗都需要使用胰岛素,但有些患者因为使用不方便和害怕疼痛等原因不愿意注射胰岛素,非入侵式的胰岛素给药途径尤其是吸入胰岛素的发展给这些糖尿病患者带来了福音。本文就吸入胰岛素的分类、优点以及临床应用情况等方面的研究进展予以综述。

引用

页码：436 / 439

页数：4

共 12 条

[1] Preferences of patients with diabetes mellitus for inhaled versus injectable insulin regimens [J].

Chancellor, Jeremy ;

Aballea, Samuel ;

Lawrence, Alison ;

Sheldon, Rob ;

Cure, Sandrine ;

Plun-Favreau, Juliette ;

Marchant, Nick .

PHARMACOECONOMICS, 2008, 26 (03) :217-234

[2] Selection and education of patients for inhaled insulin [J].

Bellary S. ;

Barnett A.H. .

Current Diabetes Reports, 2007, 7 (5) :363-368

[3]

Inhaled insulin using AERx＜sup＞?＜/sup＞ insulin Diabetes Management System （AERx＜sup＞?＜/sup＞ iDMS）[J] . Mudaliar.Expert Opinion on Investigational Drugs . 2007 (10)

[4]

AIR＜sup＞?＜/sup＞ Inhaled Insulin System: a novel insulin-delivery system for patients with diabetes[J] . Rosenstock,Muchmore,Swanson,Schmitke.Expert Review of Medical Devices . 2007 (5)

[5]

Developing a Pulmonary Insulin Delivery System for Patients with Diabetes[J] . George Dailey.Clinical Therapeutics . 2007 (6)

[6]

The diabetic lung: Relevance of alveolar microangiopathy for the use of inhaled insulin[J] . Connie C.W. Hsia,Philip Raskin.The American Journal of Medicine . 2005 (3)

[7]

Antibody Response to Inhaled Insulin in Patients with Type 1 or Type 2 Diabetes. An Analysis of Initial Phase II and III Inhaled Insulin （Exubera） Trials and a Two-Year Extension Trial[J] . S Edwin Fineberg,Tom Kawabata,Deborah Finco-Kent,Cameron Liu,Alan Krasner.The Journal of Clinical Endocrinology ＆ Metabolism . 2005 (6)

[8]

Evaluation of inhaled insulin therapy for diabetesmellitus. Siddiqui NId. Mymensingh Medical Journal . 2007

[9]

Inhaled insulin for diabetes mellitus. McMahon GT,Arky RA. The New England Journal of Medicine . 2007

[10]

Efficacy andsafety of inhaled insulin（Exubera）compared with subcutaneousinsulin therapy in patients with type 2 diabetes:results of a 6-month,randomized,comparative trial. HOLLANDER P A,BLONDE L,ROWE R,et al. Diabetes Care . 2004

← 1 2 →